Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

The Medicines Company Needs More Options Beyond Angiomax
Bloomberg
Wednesday, October 12, 2011 - 9:23am
tags:
Angiomax, Medicines Company, Teva Pharmaceuticals
Merck’s Australian Unit Wins Bid to Overturn Trial Decision on Vioxx Drug
Bloomberg
Wednesday, October 12, 2011 - 9:21am
tags:
Merck, Australia, Vioxx
Dividend Leaders Abbott, Baxter See Q3 EPS Growth
Investors.com
Wednesday, October 12, 2011 - 9:20am
tags:
earnings, dividends, Abbott Laboratories, Baxter
Seattle Genetics: Weighing Bearish And Bullish Opinions
Seeking Alpha
Tuesday, October 11, 2011 - 5:16pm
tags:
Seattle Genetics, Immunogen
AstraZeneca Loves This $100Bn Market
Motley Fool
Tuesday, October 11, 2011 - 5:14pm
tags:
AstraZeneca, China
BioSante Rising as Female Libido Drug Moves Foward
Minyanville
Tuesday, October 11, 2011 - 5:13pm
tags:
female sexual dysfunction, BioSante, LibiGel
GlaxoSmithKline grants will fund melanoma drug research
Bizjournals.com
Tuesday, October 11, 2011 - 5:11pm
tags:
GSK, melanoma, grants
Agios and Celgene: Anatomy of an Ultra-Valuable Biotech Marriage
Motley Fool
Tuesday, October 11, 2011 - 11:23am
tags:
Agios, Celgene, drug development, cancer
Sanofi's Viehbacher sees green lights ahead for Shantha
Fierce Pharma Manufacturing
Tuesday, October 11, 2011 - 11:22am
tags:
Sanofi, drug manufacturing, Shantha Biotech, Shanchol, Chris Viehbacher
Thermo Fisher Scientific Worth A Look After Sell-Off
Seeking Alpha
Tuesday, October 11, 2011 - 11:05am
tags:
Thermo Fisher, Illumina
Roche spotlights PhI efficacy of Alzheimer's antibody
Fierce Biotech
Tuesday, October 11, 2011 - 10:59am
tags:
Roche, Alzheimer's disease, gantenerumab
FDA Warns Bristol Myers Leukemia Drug Could Cause Hypertension
FOX Business
Tuesday, October 11, 2011 - 10:47am
tags:
FDA, warnings, Bristol-Myers Squibb, leukemia, Sprycel
Checking the Quality of Perrigo's Growth
Motley Fool
Tuesday, October 11, 2011 - 10:46am
tags:
Perrigo Company, Abbott Laboratories, Dr Reddy's, Bristol-Myers Squibb
A Petition To Scuttle Gilead Deal With Patent Pool
Pharmalot
Tuesday, October 11, 2011 - 10:44am
tags:
Gilead, patents, HIV, AIDS, Medicines Patent Pool
India Will Not Cap Foreign Investment In Pharma
Pharmalot
Tuesday, October 11, 2011 - 9:18am
tags:
India
Teva, Baxter, Mckesson to Pay $162 Million Punitive Damages Over Propofol
Bloomberg
Tuesday, October 11, 2011 - 9:15am
tags:
Baxter, McKesson, Teva Pharmaceuticals, settlements, propofol, anesthesia
United Therapeutics plans $210M note offering
Yahoo/AP
Tuesday, October 11, 2011 - 9:14am
tags:
United Therapeutics, stock buyback
Third Rock seeds a new approach to treating diabetes and obesity
Fierce Biotech
Monday, October 10, 2011 - 6:43pm
tags:
Third Rock, diabetes, obesity, Adipothermics
3 Companies Leading The Stem Cell Revolution
Seeking Alpha
Monday, October 10, 2011 - 6:40pm
tags:
stem cells, Geron, Neuralstem, Advanced Cell Technologies
Agony From Lipitor's Expiration Won't Be Exclusive To Pfizer
Seeking Alpha
Monday, October 10, 2011 - 6:37pm
tags:
Pfizer, generics, Lipitor, patents, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.